98665-09-9
Chemical Structure
Methyl lucidenate D
- CAS No.: 98665-09-9
- Formula:C30H40O8
- Molecular Weight:528.63
InChIKey: JOFJXWXVPFAZPK-XULWGOJYSA-N
SMILES: C[C@@]12[C@](C3=C([C@@]4([C@@](C(C)(C(CC4)=O)C)([H])CC3=O)C)C([C@H]1OC(C)=O)=O)(C(C[C@]2([H])[C@H](C)CCC(OC)=O)=O)C
Biological Activity: Methyl lucidenate D is a selective inhibitor of Epstein-Barr virus early antigen (EBV-EA) activation with an IC50 of 290 mol ratio/32 pmol TPA. Methyl lucidenate D exerts potential anti-tumor promoting activity by inhibiting TPA-induced EBV-EA activation and maintains major Raji cell survival (70%) at effective concentrations. Methyl lucidenate D can be used in the field of cancer chemoprevention[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Methyl lucidenate D | Methyl lucidenate D is a selective inhibitor of Epstein-Barr virus early antigen (EBV-EA) activation with an IC50 of 290 mol ratio/32 pmol TPA. Methyl lucidenate D exerts potential anti-tumor promoting activity by inhibiting TPA-induced EBV-EA activation and maintains major Raji cell survival (70%) at effective concentrations. Methyl lucidenate D can be used in the field of cancer chemoprevention. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
